| Line Item | 2025-03-29 | Y/Y |
|---|---|---|
| Revenue | $1.64B | +4.9% |
| Cost of Revenue | $910.2M | +2.3% |
| Gross Profit | $726.1M | +8.3% |
| R&D Expense | $33.0M | +0.0% |
| SG&A Expense | $279.3M | +10.2% |
| Operating Income | $369.9M | +8.1% |
| Interest Expense | $59.8M | -24.0% |
| Pre-tax Income | $311.9M | +19.1% |
| Income Tax | $65.7M |
| Line Item | 2025-03-29 | Y/Y |
|---|---|---|
| Cash & Equivalents | $36.8M | -42.0% |
| Accounts Receivable | $307.6M | +20.5% |
| Inventory | $654.5M | +5.1% |
| Current Assets | $1.03B | +6.4% |
| Total Assets | $4.69B | +0.1% |
| Current Liabilities | $315.3M | +7.1% |
| Long-term Debt | $920.1M | -22.8% |
| Line Item | 2025-03-29 | Y/Y |
|---|---|---|
| Operating Cash Flow | $293.6M | +6.9% |
| Capital Expenditures | $49.8M | +50.0% |
| Investing Cash Flow | -$49.8M | +4.6% |
| Financing Cash Flow | -$270.4M | -21.0% |
| Free Cash Flow | $243.8M | +1.0% |
| +26.6% |
| Net Income | $246.2M | +17.3% |
| EPS (Basic) | $7.76 | +19.9% |
| EPS (Diluted) | $7.70 | +20.1% |
| Total Liabilities |
| $1.65B |
| -14.2% |
| Stockholders' Equity | $3.03B | +10.2% |